Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
M3MTHRY -0.51%82 EV-to-EBIT is 13.87 as of Jul. 17, 2026, which is 63% below its 10-year median of 37.73. GuruFocus rates MTHRY with a GF Score™ of 82/100 and a GF Value™ of $7.91 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 470 Healthcare Providers & Services companies, M3 ranks better than 52.77% on this metric.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, M3's Enterprise Value is $7,081 Mil.
M3's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $511 Mil. Therefore, M3's EV-to-EBIT for today is 13.87.
The historical rank and industry rank for M3's EV-to-EBIT or its related term are showing as below:
MTHRY'
s EV-to-EBIT Range Over the Past 10 Years
Min: 10.38 Med: 37.73 Max: 148.93
Current: 13.87
During the past 13 years, the highest EV-to-EBIT of M3 was 148.93. The lowest was 10.38. And the median was 37.73.
MTHRY's EV-to-EBIT is ranked better than 52.77% of 470
companies
in the Healthcare Providers & Services industry
Industry Median: 15.72
vs MTHRY: 13.87
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
M3's Enterprise Value for the quarter that ended in Mar. 2026 was $6,067 Mil.
M3's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $511 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
M3 EV-to-EBIT Related Terms
M3 EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for M3's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, M3's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M3 EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, M3's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where M3's EV-to-EBIT falls into.
M3's current Enterprise Value is $7,081 Mil.
M3's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $511 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
M3 (MTHRY) has a EV-to-EBIT of 13.87 as of Jul. 17, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on M3 and its competitors. This is 63% below median its historical median of 37.73. Over the past decade, M3's EV-to-EBIT has ranged from 10.38 to 148.93. According to the industry distribution chart, M3 ranks #222 out of 470 companies in the Healthcare Providers & Services industry, placing it in the top 47.2%.
Is M3's EV-to-EBIT too high?
M3's current EV-to-EBIT of 13.87 is 63% below median its 10-year median of 37.73. Over the past 10 years, this metric has ranged from a low of 10.38 to a high of 148.93. The Healthcare Providers & Services industry median EV-to-EBIT is 15.72. M3's value of 13.87 is 11.8% below this industry median. Based on the distribution chart, M3 ranks #222 out of 470 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, M3 has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does M3's EV-to-EBIT compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, M3 ranks #222 out of 470 companies for EV-to-EBIT. This puts M3 in the upper half of its industry. The industry median EV-to-EBIT is 15.72. M3's value of 13.87 is 11.8% below this benchmark. Historically, M3's own EV-to-EBIT has ranged from 10.38 to 148.93 over the past decade. While the company's 10-year median is 37.73 vs. the industry median of 15.72, M3 has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.72, based on 470 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M3's current EV-to-EBIT of 13.87 is 11.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on M3 and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M3's current EV-to-EBIT is 13.87, which is 63% below median its own 10-year median of 37.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M3 stock overvalued right now?
Based on GuruFocus' analysis, M3 (MTHRY) is currently considered Modestly Undervalued. The stock's GF Value™ is $7.91, compared to a current price of $5.84 — trading 26.2% below its estimated fair value. The current EV-to-EBIT is 13.87, which is 63% below median its 10-year median of 37.73 and 11.8% below the Healthcare Providers & Services industry median of 15.72. M3's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For M3 (MTHRY), the current EV-to-EBIT is 13.87 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M3 (MTHRY) Overvalued in 2026?
Based on GuruFocus' analysis, M3 stock appears to be undervalued.
The current stock price of $5.84 is trading 26.2% below its estimated GF Value™ of $7.91.
GuruFocus considers M3 to be Modestly Undervalued.
Key valuation signals for MTHRY:
EV-to-EBIT: 13.87 (63% below median its 10-year median of 37.73)
GF Value™: $7.91 vs. price of $5.84 (26.2% below fair value)
Industry Position: 11.8% below the Healthcare Providers & Services median (#222 of 470)
No single metric tells the full story. See the MTHRY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M3 Inc is a Japan-based company engaged in providing medical-related services through internet-based platforms and real-world operations. The company operates six reportable segments: Medical Platform, Evidence Solutions, Career Solutions, Site Solutions, Patient Solutions, and Overseas. Its businesses include online marketing for medical professionals, clinical trial support, human resources services for medical professionals, operational support for medical institutions, and patient support services. The Overseas segment offers similar services internationally, including in the United States, the United Kingdom, China, South Korea, India, France, Germany, and Spain.
82GF Score
Get the complete analysis for MTHRY
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MTHRY has been successfully added to your 
